tenk.fyi

Autolus Therapeutics plc

AUTLNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$10.1M

496.0% YoY

Net Income

-$220.7M

5.9% YoY

EPS

$-0.86

28.3% YoY

Cash

$227.4M

5.1% YoY

FY 2024 · As of 2024-12-31